16 research outputs found
PHS168 Antipsychotic Medication use Measures for children and adolescents: Metabolic Screening for children on antipsychotics
Get PDFPHS162 Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaid
Get PDFReport of Seminar on Estate Planning
Get PDFReports from the UK/CLE Seminar on Estate Planning held July 19-20, 1974
Individualizing therapy – in search of approaches to maximize the benefit of drug treatment (II)
Get PDFAdjusting drug therapy to the individual, a common approach in clinical practice, has evolved from 1) dose adjustments based on clinical effects to 2) dose adjustments made in response to drug levels and, more recently, to 3) dose adjustments based on deoxyribonucleic acid (DNA) sequencing of drug-metabolizing enzyme genes, suggesting a slow drug metabolism phenotype. This development dates back to the middle of the 20(th )century, when several different drugs were administered on the basis of individual plasma concentration measurements. Genetic control of drug metabolism was well established by the 1960s, and pharmakokinetic-based individualized therapy was in use by 1973
Impact of the shift to Medicaid managed care on resource Utilization and costs for beneficiaries in Mississippi Medicaid
No full textPHP72 Impact of the shift to Medicaid managed care on resource Utilization and costs for beneficiaries in Mississippi Medicaid
Get PDFQuality of Care for childhood attention deficit/hyperactivity disorder: a Retrospective analysis of mississippi medicaid program
No full textDeveloping Algorithms for identifying beneficiaries with higher than expected Utilization of opioids Analgesics
No full textAntipsychotic Medication use Measures for children and adolescents: Metabolic Screening for children on antipsychotics
No full text
